GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human
GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human

Immobilized Anti-GARP&TGF beta 1 Antibody<4B1C1>, hFc Tag at 5 μg /ml (100 μl/well) on the plate. Dose response curve for GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human, His Tag with the EC50 of 1.05 μg /ml determined by ELISA.

GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human

The purity of GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human

GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human

GARP&Latent TGF Beta is a complex found on surface of many types of cells. In Tregs, GARP is involved in TCR-mediated activation of Latent TGF-β and thus promoting secretion and activation of TGF-β. Integrin αvβ8 on the surface of immune cells and other cells recognizes RGD in LAP, resulting in the release of mature TGF-β from the TGF-β&GARP complex.
Z05327
¥104,464.00

Ask us a question
Product Introduction
Species Human
Protein Construction
GARP (G139N) & Latent TGF Beta 1 Complex [His20-Leu628 (GARP (G139N)) & Leu30-Ser390 (Latent TGF Beta 1)]
Accession # Q14392 (GARP (G139N)) & P01137(Latent TGF beta 1)		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 70.3 kDa (GARP(G139N))&41.4 kDa (Latent TGF Beta 1)
Apparent Molecular Weight Due to glycosylation, the protein migrates to 75-80 kDa (GARP(G139N))&15 kDa&42-48 kDa (Latent TGF Beta 1) based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human
    • GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human

    Immobilized Anti-GARP&TGF beta 1 Antibody<4B1C1>, hFc Tag at 5 μg /ml (100 μl/well) on the plate. Dose response curve for GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human, His Tag with the EC50 of 1.05 μg /ml determined by ELISA.

  • GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human
    • GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human

    The purity of GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human
    • GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human

    GARP (G139N) &Latent TGF Beta 1 Complex, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background GARP&Latent TGF Beta is a complex found on surface of many types of cells. In Tregs, GARP is involved in TCR-mediated activation of Latent TGF-β and thus promoting secretion and activation of TGF-β. Integrin αvβ8 on the surface of immune cells and other cells recognizes RGD in LAP, resulting in the release of mature TGF-β from the TGF-β&GARP complex.
Synonyms LRRC32; GARP; LAP; TGF-beta-1; LRRC32&TGF-beta 1; LRRC32&TGFB1; TGF-β-1; LRRC32&TGF-β 1; GARP&Latent TGF Beta; GARP&Latent TGF Beta 1

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.